Clinical Trial: Geriatric Assessment-Guided Treatment Selection in Older Adults With Acute Myeloid Leukemia

U.S., July 30 -- ClinicalTrials.gov registry received information related to the study (NCT07735208) titled 'Geriatric Assessment-Guided Treatment Selection in Older Adults With Acute Myeloid Leukemia' on June 25.

Brief Summary: This is a phase 2 randomized controlled trial to evaluate whether a geriatric assessment (GA)-guided treatment strategy reduces treatment-related toxicity and improves patient-centered outcomes compared with usual oncologist-directed care in adults aged 60 years and older with newly diagnosed AML.

Study Start Date: Dec. 01, 2026

Study Type: INTERVENTIONAL

Condition: Acute Myeloid Leukemia

Intervention: DRUG: GA-directed treatment regimens

Fit, vulnerable, and frail patients will receive predefined regimens b...